$VRDN

$23.34 +$0.97 (4.34%) Close

$VRDN Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 113.3M shares outstanding

Who owns VRDN?

By type of holder

Institutions 100.0% Insiders 0.0% Everyone else 0.0%

Concentration Top 10 holders own 74.0%

Fairmount Healthcare Fund II GP LLC 15.2% · FMR LLC 14.7%

Institutional ownership

100.0%

+0.8 pts vs last qtr

Institutional holders

213

-11 vs last qtr

Net shares bought

+23.6M

by institutions in Q2 2026

New / sold out

46 / 57

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

Kynam Capital Management, LP +4.1M
Paradigm Biocapital Advisors LP +3.6M

Biggest sellers in Q2 2026

Citadel Advisors LLC −2.3M
Balyasny Asset Management L.P. −1.0M

Who is planning to sell?

Notices of proposed sale, last 12 months

$498K

5 notices from 4 people

Shares covered

16.4K

0.01% of the company

Arranged in advance

of the value is under a 10b5-1 plan

Under a 10b5-1 plan No plan

Largest proposed sellers

Mahoney Stephen F. Officer $224K
Tousignant Jennifer Officer $121K

Every notice on Red Flags →

A Form 144 is notice of a planned sale, not the sale itself. What insiders actually sold is on Insider Transactions.

Is your stake being diluted?

Diluted share count, FY2020–FY2023

+1158.2%

+132.59% a year

Each share's claim on the business

−92.1%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

— vs $105M

over 4 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years27% 3–5 years40% 1–3 years12% Under 1 year21%

Quarterly turnover

24.4%

of institutional shares changed hands

Top 10 managers, median time held

4.5 years

Super Investors

Investment managers reporting VRDN on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
F FMR LLC	16.6M	14.66%	+1.2M (+8.0%)	2022	0.0%
Shares held by quarter Peak holding16.6M (Q2'26) Change over 8 quarters+5.4M Share of the company14.660% FMR LLC's full portfolio →
B BlackRock, Inc.	8.6M	7.55%	+720.0K (+9.2%)	≤2021	0.0%
Shares held by quarter Peak holding8.6M (Q2'26) Change over 8 quarters+3.7M Share of the company7.550% BlackRock, Inc.'s full portfolio →

FMR LLC

16.6M

% of company

14.66%

Change vs last qtr

+1.2M (+8.0%)

Held since

2022

BlackRock, Inc.

8.6M

% of company

7.55%

Change vs last qtr

+720.0K (+9.2%)

Held since

≤2021

28 more super investors behind a free account

See every manager holding Viridian Therapeutics, Inc., how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting VRDN on Form N-PORT; together they hold 41.7% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
SS State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR Series Trust	$72.1M	3.9M	3.46%	0.67%	June 30, 2026
VT Vanguard Total Stock Market Index Fund Vanguard Index Funds	$61.3M	3.3M	2.95%	0.00%	June 30, 2026

State Street(R) SPDR(R) S&P(R) Biotech ETF

SPDR Series Trust

Position value

$72.1M

% of company

3.46%

% of the fund

0.67%

As of

June 30, 2026

Vanguard Total Stock Market Index Fund

Vanguard Index Funds

Position value

$61.3M

% of company

2.95%

% of the fund

0.00%

As of

June 30, 2026

23 more funds behind a free account

See every fund holding Viridian Therapeutics, Inc. and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
FH Fairmount Healthcare Fund II GP LLC 5%+ holder 13D · 14.0%	17.2M	15.18%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company15.180% Disclosed stake13D · 14.0% View the 13D/G filing →
TR Tripuraneni Radhika Insider	40.0K	0.04%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company0.040% Tripuraneni Radhika's insider activity →

Fairmount Healthcare Fund II GP LLC

5%+ holder13D · 14.0%

17.2M

% of company

15.18%

Change vs last qtr

—

Held since

—

Tripuraneni Radhika

Insider

40.0K

% of company

0.04%

Change vs last qtr

—

Held since

—

3 more holders behind a free account

See every insider and 5%+ holder of Viridian Therapeutics, Inc..

Comments